Concepedia

Tuoyu Cao

TC

Statistics

Publications

6

Citations

395

H-Index

6

Active since

2018

Affiliations

Xiangya Hospital Central South University(Current)

Central South University

Third Xiangya Hospital

Guangdong Pharmaceutical University

Hunan University

Tuoyu Cao is an author at Xiangya Hospital Central South University specializing in oncology, medicine, and molecular oncology.

Publications per year

2018–2023

6

Publications

6

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

Linglong Yin, Youhong Liu, Yuchong Peng et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 127 citations · Full text

, , +16

UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications

Yingxue Gao, Yijun Liu, Youhong Liu et al. · Cancer Letters · 2021 · 77 citations

, , +17

Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition

Xiaohui Yu, Youhong Liu, Linglong Yin et al. · Oncogene · 2018 · 63 citations · Full text

, , +15

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Bowen Yuan, Youhong Liu, Xiaohui Yu et al. · Cell Death and Disease · 2018 · 57 citations · Full text

, , +17

USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis

Yuchong Peng, Youhong Liu, Yingxue Gao et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 48 citations · Full text

, , +17

1–5 of 6